Medication info
PimaDuet Tablets 30/2.5 mg

PimaDuet Tablets 30/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
White, rounded square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300139 · Approved 2023.01.06 · Insurance code 663608690

Summary

Main use
Treatment of essential hypertension inadequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Used as an additional treatment option for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of Prasugrel Potassium.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Precautions

This medication poses a significant risk of serious harm or death to the fetus or newborn if taken during pregnancy, especially during the second and third trimesters, so usage should be discontinued immediately upon confirmation of pregnancy. Patients allergic to this drug's active ingredient or similar components, pregnant or breastfeeding women, patients undergoing kidney dialysis, those with severe liver dysfunction, patients with bile duct obstruction, patients with specific genetic lactose intolerance, patients with severe aortic stenosis, and those in a state of shock should not take this medication. Particular caution is required for patients with low blood volume or sodium deficiency, impaired kidney function, renal artery hypertension, aortic or mitral stenosis, obstruction, and hypertrophic cardiomyopathy, primary aldosteronism, severe hypotension, older adults, and those allergic to certain dyes contained in this drug. While taking this medication, symptoms such as dizziness, headache, facial swelling, urination problems, insomnia, flushing, etc., may occur, and in rare cases serious kidney issues or blood pressure drops can arise. Blood pressure may drop too low, or electrolyte imbalances may occur; therefore, individuals taking significant diuretics or consuming low sodium should manage their condition carefully before taking the medication and regularly monitor blood pressure and electrolyte levels during use. This medication may interact with other antihypertensives or potassium-sparing diuretics, certain anti-inflammatory drugs, lithium, ketoconazole, etc., so patients taking other medications should consult their doctor or pharmacist. During pregnancy, risks to the fetus may necessitate avoidance if possible, and while breastfeeding, transmission of the drug through breast milk is possible; hence, its use is not recommended. Safety and efficacy in children under 18 years are not established, and caution is required for elderly patients aged over 70 as they may be more sensitive to the drug. Patients with severe liver impairment should not take this medication. In case of overdose, severe hypotension or cardiac arrhythmias can occur; hence, it is crucial to seek medical treatment immediately, and in some cases, gastric lavage or activated charcoal administration may help. Keep this medication out of reach of children and avoid transferring to another container to prevent quality deterioration or accidents.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urinary disorders
  • insomnia
  • flushing
  • syncope
  • sedation
Show 134 more
  • migraine
  • indigestion
  • vomiting
  • nausea
  • abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening of cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colon cancer
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of back pain
  • osteoarthritis
  • arthrosis
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • epilepsy
  • polyneuropathy
  • hemiplegia
  • dementia
  • Parkinson's syndrome
  • gait disturbance
  • optic nerve damage
  • optic neuritis
  • blepharospasm
  • facial pain
  • vertebrobasilar artery syndrome
  • restless legs
  • ischemic neuropathy
  • sensory disturbance
  • tremor
  • extrapyramidal disorder
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • loss of appetite
  • change in bowel habits
  • dry mouth
  • pancreatitis
  • hyperglycemia
  • malaise
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • cough
  • shortness of breath
  • rhinitis
  • hair loss
  • hyperhidrosis
  • purpura
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbance
  • increased frequency of urination
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzyme levels
  • pruritus
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinus block
  • atrioventricular block
  • abdominal discomfort
  • epigastric pain
  • diarrhea
  • loose stools
  • cutaneous erythema
  • maculopapular rash
  • heaviness
  • heat sensation
  • decreased glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it should be stored safely at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.